Maruho receives manufacturing and marketing approval in Japan for infantile hemangioma treatment "Hemangiol® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories
News Release
Maruho receives manufacturing and marketing approval in Japan for infantile hemangioma treatment "Hemangiol® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories
